Atorvastatin Calcium Tablet
Product Images NDC 33342-316

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 33342-316). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Macleods Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

454 (Atorvastatin Calcium 10mg 500s)

Label for Atorvastatin Calcium Tablets, USP 10 mg, oral tablet by Macleods Pharmaceuticals Limited. The label includes storage instructions, dosage note to see package insert, and states the product is manufactured in India. Packaging contains 500 tablets. Barcodes and NDC 33342-315-15 are shown.*

FDA Label Image

565 (Atorvastatin Calcium 10mg 90s)

Label for Atorvastatin Calcium Tablets, USP 10 mg by Macleods Pharmaceuticals Limited. The label indicates it contains 90 film-coated tablets. It includes storage instructions, manufacturer details, and a barcode. The product is marked Rx Only and produced by Macleods Pharma USA, Inc., Princeton, NJ, and Macleods Pharmaceuticals Ltd., India.*

FDA Label Image

565 (Atorvastatin Calcium 20mg 500s)

Label for Atorvastatin Calcium Tablets USP 20 mg by Macleods Pharmaceuticals Limited. The label shows the strength as 20 mg per tablet, with a total count of 500 tablets. It includes storage instructions, the manufacturer address in India, and an NDC number 33342-316-15. The label also notes the product is for prescription use only.*

FDA Label Image

585 (Atorvastatin Calcium 20mg 90s)

Label for Atorvastatin Calcium Tablets USP, 20 mg strength, oral tablet dosage form. The package contains 90 tablets and is manufactured for Macleods Pharma USA, Inc. in Princeton, NJ, by Macleods Pharmaceuticals Ltd., India. The label includes storage instructions and a barcode.*

FDA Label Image

565 (Atorvastatin Calcium 40mg 500s)

Label for Atorvastatin Calcium Tablets, USP 40 mg oral tablets, manufactured by Macleods Pharmaceuticals Limited. The label indicates a package size of 500 tablets and includes storage instructions, dosage reference, and product origin as India. The labeler is Macleods Pharma USA, Inc.*

FDA Label Image

505 (Atorvastatin Calcium 40mg 90s)

Label for Atorvastatin Calcium Tablets, USP 40 mg oral tablets, manufactured by Macleods Pharmaceuticals Ltd. and labeled by Macleods Pharma USA, Inc. The label includes storage instructions, dosage note, barcodes, and indicates a quantity of 90 tablets. The product is noted as made in India.*

FDA Label Image

787 (Atorvastatin Calcium 80mg 500s)

Label for Atorvastatin Calcium Tablets, USP 80 mg, oral tablets, package of 500 tablets. Manufactured by Macleods Pharmaceuticals Ltd., India and labeled for Macleods Pharma USA, Inc. The label includes storage instructions and dispensing information.*

FDA Label Image

898 (Atorvastatin Calcium 80mg 90s)

Label for Atorvastatin Calcium Tablets, USP 80 mg by Macleods Pharmaceuticals Limited. The film-coated tablet contains atorvastatin 80 mg (equivalent to 82.72 mg atorvastatin calcium anhydrous, USP). The label includes storage instructions and indicates the package contains 90 tablets, manufactured in India for Macleods Pharma USA, Inc.*

FDA Label Image

Atorvastatine-calcium-fig-1 (Atorvastatine Calcium Fig 1)

A line graph comparing cumulative incidence percentages over 3.5 years for Atorvastatin calcium and placebo groups. The graph shows two lines representing incidence rates, with Atorvastatin consistently lower than placebo. A hazard ratio (HR=0.64) and p-value (p=0.0005) are noted below the graph, indicating statistical analysis results.*

FDA Label Image

Atorvastatine-calcium-fig-2 (Atorvastatine Calcium Fig 2)

A Kaplan-Meier cumulative hazard curve comparing Atorvastatin to placebo over a 4-year follow-up period. The x-axis represents time in years to the first primary endpoint, and the y-axis shows cumulative hazard percentage. The graph depicts lower cumulative hazard for Atorvastatin versus placebo, with hazard ratio and p-value indicated.*

FDA Label Image

Atorvastatine-calcium-fig-3 (Atorvastatine Calcium Fig 3)

A line graph depicting time to first major cardiovascular endpoint over 5 years for Atorvastatin 10 mg and 80 mg doses. The graph shows the percentage of subjects experiencing the event on the vertical axis and years on the horizontal axis, with separate lines for 10 mg and 80 mg doses.*

FDA Label Image

Atorvastatine-calcium-structure (Atorvastatine Calcium Structure)

Chemical structure of atorvastatin calcium, showing its molecular arrangement and the calcium salt form with associated water molecules.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.